ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Clinical trials for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER trials appear
Sign up with your email to follow new studies for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Broccoli compound may shield hearts from chemo damage
Disease control Recruiting nowThis trial investigates whether sulforaphane, a nutrient found in broccoli, can reduce heart damage caused by the chemotherapy drug doxorubicin in breast cancer patients. About 70 participants will receive either sulforaphane or a placebo alongside their chemotherapy. The study m…
Matched conditions: ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Texas Tech University Health Sciences Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
VR headset teaches breast cancer survivors about heart risks
Knowledge-focused Recruiting nowThis study tests a virtual reality program called SurviVRSE that teaches breast cancer survivors about heart health. Thirty women currently receiving certain cancer treatments will use the VR headset during one infusion session. Researchers will measure how much they learn, how e…
Matched conditions: ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC